A team of scientists with The Cancer Genome Atlas program reports their genetic characterization of 800 breast tumors, including finding some of the genetic causes of the…

The most comprehensive analysis yet of breast cancer shows that one of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast…

A natural substance found in the surrounding tissue of a tumor may be a promising weapon to stop triple negative breast cancer from metastasizing.

A preclinical…

Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more…

Having type 2 diabetes appears to give post-menopausal women a 27% higher risk of developing breast cancer, according to a new study published in the British Journal of Cancer…

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been…

The invasion of cancer cells into the lymph vessels that connect the breast to surrounding lymph nodes is the first step leading to the metastasis, or spread, of cancer throughout the body. Metastasis…

Young women at high familial risk for breast cancer may see an even greater risk from diagnostic scans that expose them to chest radiation, including mammograms, researchers…

The study, published today in Cancer Epidemiology, Biomarkers and Prevention is the largest of its kind in Australia and one of the largest in the world. It followed about…

Women carrying a mutation in the BRCA1- or BRCA2- genes (which control the suppression of breast and ovarian cancer) who have undergone diagnostic radiation to the chest…

WOMEN having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they…

Doing housework for at least six hours a day could reduce the risk of developing breast cancer by up to 13 percent, new findings suggest.

Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography…

Roche Holding AG, the world’s biggest maker of cancer drugs, faces a testing time in its breast cancer business as a near-term threat to Herceptin, its third-biggest seller, could take…

A new survey released today by the American Society of Plastic Surgeons (ASPS) shows that 89 percent of women want to see what breast reconstruction surgery results…

More women are getting the word that they may have breasts too dense for mammograms to give a good picture. What’s not so clear is what to make of that…

For the majority of older, early-stage breast cancer patients, radiation therapy following breast conserving surgery may help prevent the need for a later mastectomy,…

Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will…

The natural plant compound phenethyl isothiocyanate (PEITC) hinders the development of mammary tumors in a mouse model with similarities to human breast cancer progression, according to a study…

Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of…

Among postmenopausal women with advanced breast cancer that had become resistant to hormonal therapy, the combination of Afinitor® (everolimus) and Aromasin® (exemestane) delayed cancer progression to a greater extent than…

Older women who eat a lot of starchy and sweet carbohydrates may be at increased risk of a less common but deadlier form of breast cancer, according to…

Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University…

Researchers at the University of Michigan Comprehensive Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The…

Galena Biopharma said its breast cancer vaccine received a patent granting it exclusivity until 2028, sending its shares up as much as 35 percent.

The vaccine, NeuVax, gives immunity…